Calvin Yu
Net Worth
Last updated:
What is Calvin Yu net worth?
The estimated net worth of Mr. Calvin Yu is at least $9,241,358 as of 6 Jul 2021. He owns shares worth $164,108 as insider, has earned $6,852,030 from insider trading and has received compensation worth at least $2,225,220 in Alector, Inc..
What is the salary of Calvin Yu?
Mr. Calvin Yu salary is $370,870 per year as Vice President of Fin. in Alector, Inc..
How old is Calvin Yu?
Mr. Calvin Yu is 49 years old, born in 1976.
What stocks does Calvin Yu currently own?
As insider, Mr. Calvin Yu owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Alector, Inc. (ALEC) | Vice President of Fin. | 76,686 | $2.14 | $164,108 |
What does Alector, Inc. do?
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.
Calvin Yu insider trading
Alector, Inc.
Mr. Calvin Yu has made 10 insider trades between 2019-2021, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 110,840 units of ALEC stock on 2 Jul 2021. As of 6 Jul 2021 he still owns at least 76,686 units of ALEC stock.
Alector key executives
Alector, Inc. executives and other stock owners filed with the SEC:
- Dr. Arnon Rosenthal (69) Co-Founder, Chief Executive Officer & Director
- Dr. Robert Paul M.D., Ph.D. (57) Advisor
- Dr. Robert S. King (62) Chief Devel. Officer
- Dr. Tillman Ulf Gerngross Ph.D. (61) Co-Founder & Chairman
- Mr. Calvin Yu (49) Vice President of Fin.